Cyclic AMP mediates endothelial protection by nitric oxide

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Endothelial cells are vital for vascular function.
• Tumor necrosis factor-alpha (TNF-alpha) induces endothelial cell death, contributing to vascular damage.
• Nitric oxide (NO) donors are explored for cytoprotective effects.

Purpose of the Study:

• To investigate the protective effects of S-nitroso-N-acetyl-D,L-penicillamine (SNAP) against TNF-alpha-induced endothelial cell death.
• To elucidate the intracellular signaling pathways involved in NO-mediated endothelial cell protection.

Main Methods:

• Endothelial cells were incubated with TNF-alpha and varying concentrations of SNAP.
• Inhibitors of adenylyl cyclase, protein kinase A (PKA), and protein kinase G (PKG) were used.
• Cyclic GMP (cGMP) and cyclic AMP (cAMP) levels were measured.
• NO scavenging was employed to assess NO dependency.

Main Results:

• SNAP significantly protected endothelial cells from TNF-alpha toxicity in a dose-dependent manner.
• SNAP-induced protection was dependent on adenylyl cyclase activity and mimicked by cAMP.
• SNAP increased both cGMP and cAMP levels, with increases abrogated by NO scavenging.
• Protection was abolished by PKA inhibition but unaffected by PKG inhibition.

Conclusions:

• Cyclic AMP plays a critical role in mediating nitric oxide-induced endothelial cell protection against TNF-alpha.
• The mechanism may involve cGMP-dependent inhibition of cAMP hydrolysis.
• NO-dependent endothelial protection could result from cAMP-mediated up-regulation of antioxidant proteins or down-regulation of cytotoxic processes.